↓ Skip to main content

Modern Anesthetics

Overview of attention for book
Cover of 'Modern Anesthetics'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Site of Anesthetic Action
  3. Altmetric Badge
    Chapter 2 Inhibitory Ligand-Gated Ion Channels as Substrates for General Anesthetic Actions
  4. Altmetric Badge
    Chapter 3 Actions of Anesthetics on Excitatory Transmitter-Gated Channels
  5. Altmetric Badge
    Chapter 4 Voltage-Gated Ion Channels
  6. Altmetric Badge
    Chapter 5 G-Protein-Coupled Receptors
  7. Altmetric Badge
    Chapter 6 Inhalation Anaesthesia: From Diethyl Ether to Xenon
  8. Altmetric Badge
    Chapter 7 General Anesthetics and Long-Term Neurotoxicity
  9. Altmetric Badge
    Chapter 8 Special Aspects of Pharmacokinetics of Inhalation Anesthesia
  10. Altmetric Badge
    Chapter 9 Inhalational Anaesthetics and Cardioprotection
  11. Altmetric Badge
    Chapter 10 Non-Immobilizing Inhalational Anesthetic-Like Compounds
  12. Altmetric Badge
    Chapter 11 Propofol.
  13. Altmetric Badge
    Chapter 12 Pharmacokinetics and pharmacodynamics of GPI 15715 or fospropofol (Aquavan injection) - a water-soluble propofol prodrug.
  14. Altmetric Badge
    Chapter 13 Etomidate and other non-barbiturates.
  15. Altmetric Badge
    Chapter 14 Remifentanil and Other Opioids
  16. Altmetric Badge
    Chapter 15 Ketamine.
  17. Altmetric Badge
    Chapter 16 Midazolam and Other Benzodiazepines
  18. Altmetric Badge
    Chapter 17 The Effect of Altered Physiological States on Intravenous Anesthetics
  19. Altmetric Badge
    Chapter 18 Anesthetics Drug Pharmacodynamics
  20. Altmetric Badge
    Chapter 19 Defining Depth of Anesthesia
  21. Altmetric Badge
    Chapter 20 Target Controlled Anaesthetic Drug Dosing
  22. Altmetric Badge
    Chapter 21 Advanced Technologies and Devices for Inhalational Anesthetic Drug Dosing
  23. Altmetric Badge
    Chapter 22 Hypnotic and Opioid Anesthetic Drug Interactions on the CNS, Focus on Response Surface Modeling
Attention for Chapter 16: Midazolam and Other Benzodiazepines
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
3 X users
wikipedia
16 Wikipedia pages

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
338 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Midazolam and Other Benzodiazepines
Chapter number 16
Book title
Modern Anesthetics
Published in
Handbook of experimental pharmacology, January 2008
DOI 10.1007/978-3-540-74806-9_16
Pubmed ID
Book ISBNs
978-3-54-072813-9, 978-3-54-074806-9
Authors

K. T. Olkkola, J. Ahonen, Olkkola, K. T., Ahonen, J.

Abstract

The actions of benzodiazepines are due to the potentiation of the neural inhibition that is mediated by gamma-aminobutyric acid (GABA). Practically all effects of the benzodiazepines result from their actions on the ionotropic GABA(A) receptors in the central nervous system. Benzodiazepines do not activate GABA(A) receptors directly but they require GABA. The main effects of benzodiazepines are sedation, hypnosis, decreased anxiety, anterograde amnesia, centrally mediated muscle relaxation and anti-convulsant activity. In addition to their action on the central nervous system, benzodiazepines have a dose-dependent ventilatory depressant effect and they also cause a modest reduction in arterial blood pressure and an increase in heart rate as a result of a decrease of systemic vascular resistance. The four benzodiazepines, widely used in clinical anaesthesia, are the agonists midazolam, diazepam and lorazepam and the antagonist flumazenil. Midazolam, diazepam and flumazenil are metabolized by cytochrome P450 (CYP) enzymes and by glucuronide conjugation whereas lorazepam directly undergoes glucuronide conjugation. CYP3A4 is important in the biotransformation of both midazolam and diazepam. CYP2C19 is important in the biotransformation of diazepam. Liver and renal dysfunction have only a minor effect on the pharmacokinetics of lorazepam but they slow down the elimination of the other benzodiazepines used in clinical anaesthesia. The duration of action of all benzodiazepines is strongly dependent on the duration of their administration. Based on clinical studies and computer simulations, midazolam has the shortest recovery profile followed by lorazepam and diazepam. Being metabolized by CYP enzymes, midazolam and diazepam have many clinically significant interactions with inhibitors and inducers of CYP3A4 and 2C19. In addition to pharmacokinetic interactions, benzodiazepines have synergistic interactions with other hypnotics and opioids. Midazolam, diazepam and lorazepam are widely used for sedation and to some extent also for induction and maintenance of anaesthesia. Flumazenil is very useful in reversing benzodiazepine-induced sedation as well as to diagnose or treat benzodiazepine overdose.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 338 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Sweden 1 <1%
Russia 1 <1%
Germany 1 <1%
Unknown 334 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 44 13%
Student > Bachelor 42 12%
Researcher 36 11%
Student > Ph. D. Student 26 8%
Student > Postgraduate 21 6%
Other 54 16%
Unknown 115 34%
Readers by discipline Count As %
Medicine and Dentistry 88 26%
Pharmacology, Toxicology and Pharmaceutical Science 31 9%
Agricultural and Biological Sciences 22 7%
Biochemistry, Genetics and Molecular Biology 14 4%
Neuroscience 13 4%
Other 51 15%
Unknown 119 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2022.
All research outputs
#6,685,056
of 24,677,985 outputs
Outputs from Handbook of experimental pharmacology
#191
of 673 outputs
Outputs of similar age
#36,390
of 166,055 outputs
Outputs of similar age from Handbook of experimental pharmacology
#6
of 16 outputs
Altmetric has tracked 24,677,985 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 673 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,055 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.